Stockscreener 앱 받기
1.05
0.67%
-0.0071
시간 외 거래:
2.58
1.53
+145.71%
전일 마감가:
$1.0571
열려 있는:
$1.0762
하루 거래량:
4,460
Relative Volume:
0.25
시가총액:
$7.69M
수익:
-
순이익/손실:
$22.68M
주가수익비율:
1.9811
EPS:
0.53
순현금흐름:
$-1.94M
1주 성능:
-6.25%
1개월 성능:
-14.63%
6개월 성능:
-41.34%
1년 성능:
-49.76%
1일 변동 폭
$1.05
$1.08
1주일 범위
$1.05
$1.17
52주 변동 폭
$1.03
$2.4229
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
명칭
Pharmacyte Biotech Inc
전화
(917) 595.2850
주소
23046 AVENIDA DE LA CARLOTA, SUITE 600, LAGUNA HILLS
PMCB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.27 | 417.90M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.47 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.158 | 333.44M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
JUNE
Dhandho Junoon Etf
|
10.87 | 206.34M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.20 | 177.85M | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc 주식(PMCB)의 최신 뉴스
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Up 1.7% – Still a Buy? - Defense World
PharmaCyte Biotech holds annual meeting, elects directors By Investing.com - Investing.com South Africa
PharmaCyte Biotech holds annual meeting, elects directors - Investing.com
PMCB stock touches 52-week low at $1.03 amid market challenges By Investing.com - Investing.com South Africa
PMCB stock touches 52-week low at $1.03 amid market challenges - Investing.com Australia
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Down 5.3% – Here’s What Happened - Defense World
Short Interest in PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Grows By 82.3% - Defense World
PMCB stock touches 52-week low at $1.38 amid market challenges - Investing.com India
PharmaCyte Biotech Inc. (PMCB) reports earnings - Quartz
PharmaCyte Biotech, Inc. SEC 10-Q Report - TradingView
PharmaCyte Biotech (OTCMKTS:PMCBD) Shares Down 1.1% – Here’s What Happened - Defense World
Contrasting PharmaCyte Biotech (OTCMKTS:PMCBD) & Tarsus Pharmaceuticals (NASDAQ:TARS) - Defense World
PharmaCyte Biotech appoints new accounting firm By Investing.com - Investing.com South Africa
PharmaCyte Biotech appoints new accounting firm - Investing.com
Top Penny Stocks To Watch In February 2025 - Simply Wall St
PharmaCyte Biotech (OTCMKTS:PMCBD) and Tenaya Therapeutics (NASDAQ:TNYA) Head to Head Analysis - The AM Reporter
Head to Head Survey: Tenaya Therapeutics (NASDAQ:TNYA) and PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World
Pancreatic Cancer Precision Medicine Market Report, 2030 - Grand View Research
Malignant Ascites Treatment Market: Trends, Growth, - openPR
Pancreatic Cancer Treatment Market to Surge to USD 10.2 - GlobeNewswire
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Up 0.1% – What’s Next? - Defense World
Global Ascites Market Size and Trends, Forecast 2025-2035: Unlocking Key Insights for Strategic Growth – Custom Market Insights - BioSpace
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Shares Sold by Geode Capital Management LLC - Defense World
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 1.5% Higher – Time to Buy? - Defense World
PharmaCyte Biotech (OTCMKTS:PMCBD) Stock Price Up 1.5% – Still a Buy? - Defense World
Comparing Vaxcyte (NASDAQ:PCVX) & PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World
Financial Comparison: Coeptis Therapeutics (NASDAQ:COEP) & PharmaCyte Biotech (NASDAQ:PMCB) - Defense World
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com
CXApp (NASDAQ:CXAI) & Aware (NASDAQ:AWRE) Financial Contrast - Defense World
Jasper Therapeutics (NASDAQ:JSPR) versus PharmaCyte Biotech (OTCMKTS:PMCBD) Head to Head Comparison - Defense World
Zacks Research Issues Positive Estimate for SRPT Earnings - Defense World
T-Mobile US, Inc. to Present at the Wells Fargo TMT Summit - Business Wire
Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference - Business Wire
PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders - Business Wire
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Announces Completion of Liquidation - Business Wire
HubSpot to Present at the Wells Fargo Technology Conference - Business Wire
MTCH Investors Have Opportunity to Lead Match Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
SUM Investors Have the Opportunity to Join Investigation of Summit Materials, Inc. with the Schall Law Firm - Business Wire
Glancy Prongay & Murray LLP Announces Investigation of Triumph Group, Inc. (TGI) - Business Wire
Glancy Prongay & Murray LLP Announces Investigation of TruBridge, Inc. (f//k/a Computer Programs and Systems, Inc.) (TBRG) - Business Wire
Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Business Wire
EMCOR Group, Inc. to Participate at the UBS Global Industrials and Transportation Conference - Business Wire
Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 Inhibitor - Business Wire
Shareholder Alert: Ademi LLP Investigates Whether Summit Materials, Inc. is Obtaining a Fair Price for its Public Shareholders - Business Wire
INNOVID INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Innovid Corp.CTV - Business Wire
Excelerate Energy to Participate at Capital One Securities Energy Conference - Business Wire
Community Health Systems Announces Definitive Agreement to Sell ShorePoint Health System in Florida - Business Wire
Savara Announces New Employment Inducement Grant - Business Wire
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX) - Business Wire
Vena Recognized as a Challenger in the 2024 Gartner® Magic Quadrant™ for Financial Planning Software - Business Wire
Pharmacyte Biotech Inc (PMCB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.01%
자본화:
|
볼륨(24시간):